display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - triple negative
mBC - Triple negative (TNBC) - 1st Line (L1)
paclitaxel
nab-paclitaxel FUTURE-SUPER_immunomodulatory subtype

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons